Tarsus Pharmaceuticals, Inc.
TARS
$36.85
$2.226.41%
Headlines
5/1/2024
-
Globe Newswire
4/29/2024
-
ETF Channel
4/25/2024
-
Stock Options Channel
4/23/2024
-
TipRanks Financial Blog
4/23/2024
-
The Fly
4/23/2024
-
Globe Newswire
4/21/2024
-
Zolmax
4/13/2024
-
Zolmax
4/9/2024
-
Insider Monkey
4/8/2024
-
Zacks Investment Research
4/4/2024
-
Insider Monkey
4/1/2024
-
Zacks Investment Research
3/31/2024
-
Ticker Report
3/22/2024
-
Ticker Report
3/22/2024
-
Ticker Report
3/20/2024
-
Zolmax
3/17/2024
-
Zolmax
3/16/2024
-
Ars Technica
3/12/2024
-
Tickeron - Stocks
3/9/2024
-
Zolmax
3/8/2024
-
Seeking Alpha - Long Ideas
3/8/2024
-
SeekingAlpha
3/7/2024
-
Ticker Report
3/6/2024
-
MediaPost Marketing News
Filings
Tuesday, February 27, 2024
Sunday, December 31, 2023
Week of May 6 and 10 (est)
Price History
--
Corporate Info
949 409 1801
15440 Laguna Canyon Road
Irvine, CA 92618
Irvine, CA 92618
Business Description
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for eye care in the United States. The...
more